Author

R. Sprung

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Organism:mouse· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1

Frequent Co-Authors

P. E. Gilmore· 2 shared R. R. Townsend· 2 shared A. Gruszczynska· 1 shared A. Joseph· 1 shared A. Kumar· 1 shared A. Panfil· 1 shared A. S. Yilmaz· 1 shared B. Holmes· 1 shared

Activity by Year

2023-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

P. E. Gilmore

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

HTLV-1 infected T cells cause bone loss via small extracellular vesicles

N. K. Pokhrel, A. Panfil, H. Habib, S. Seeniraj, A. Joseph, D. Rauch, R. Sprung, P. E. Gilmore, Q. Zhang, R. R. Townsend, L. Yu, A. S. Yilmaz, R. Aurora, W. Park, L. Ratner, , D. J. Veis

This study shows HTLV-1 infected T cells release small extracellular vesicles that promote bone loss by stimulating osteoclasts, independent of RANKL expression.

Journal of Extracellular Vesicles · Oct 10, 2024Peer-reviewedCancer Biology

Missense mutations in Myc Box I influence MYC cellular localization, mRNA partitioning and turnover to promote leukemogenesis

N. Arthur, K. A. Christensen, K. Mannino, M. Ruzinova, A. Kumar, A. Gruszczynska, R. B. Day, P. Erdmann-Gilmore, Y. Mi, R. Sprung, C. R. York, D. H. Spencer, R. Townsend, S. M. Sykes, F. Ferraro

This study shows that MBI MYC mutations alter MYC localization and disrupt mRNA subcellular distribution and turnover, promoting leukemogenesis.

bioRxiv · Oct 22, 2023 · PreprintCancer Biology

Targeted proteomic quantitation of NRF2 signaling and predictive biomarkers in HNSCC

N. Wamsley, E. Wilkerson, L. Guan, K. LaPak, T. Schrank, B. Holmes, R. Sprung, P. E. Gilmore, S. Gerndt, R. Jackson, R. Paniello, P. Pipkorn, S. V. Puram, J. Rich, R. R. Townsend, , M. B. Major

This paper develops a targeted proteomics assay to quantify NRF2 pathway components and clinical biomarkers in HNSCC, identifying correlations between NRF2 activity, HPV infection, and immune markers.

bioRxiv · Mar 13, 2023Cancer Biology